Daewoong Pharma대웅제약

Predicted impact: Low

Commentary on speculative future profit from an early-stage investment; no concrete financial event or size given.

Predicted impact: Medium

Police raid on holding company over alleged kickbacks to hundreds of hospitals; no penalty size known.

Predicted impact: Low

Smart hospital AI system repeats earlier supply and deployment news.

Predicted impact: Low

AI smart hospital launch repeats earlier AI monitoring system supply news.

Predicted impact: Low

Same Ajou University Hospital supply news as the other item; small relative to revenue

Predicted impact: Low

Hospital supply of monitoring system to 342 beds; tiny versus ₩1.6T revenue

Predicted impact: Low

Same clinical trial result already reported in the last 14 days.

Predicted impact: Low

Clinical trial result on a shorter eradication regimen; mixed, with a guidance cut reported earlier.

Predicted impact: Low

Shortened treatment course for a drug is a modest product update.

Predicted impact: Low

Medical education event for Nabota in Latin America; small and promotional with no size given.

Predicted impact: Low

Academic event in Argentina for Nabota; routine promotion with no financial size disclosed.

Predicted impact: Medium· Actual: −10.0% vs sector, volume 1.1× normal (5 trading days)

Earnings outlook cut on Pecsufly sales shift; target down 4.8%.

Predicted impact: Low· Actual: −8.8% vs sector, volume 1.2× normal (5 trading days)

New manufacturing facility plan; size and cost not disclosed.

Predicted impact: Low· Actual: −2.8% vs sector, volume 1.5× normal (5 trading days)

Routine charitable PC donation; immaterial to the company's finances.